Colonoscopy Bowel Preparation Drugs Market – Market Insights
Colonoscopy is an important screening test for detecting colorectal cancer. Colonoscopy is dependent on pre-procedure called as colonoscopy bowel preparation where the cleansing of colon is done in the patients undergoing colonoscopy.
The global colonoscopy bowel preparation drugs market was valued at US$ 1,574.9 million in 2018 and is expected to exhibit a CAGR of 4.9% over the forecast period (2019-2027).
Figure 1. Global Colonoscopy Bowel Preparation Drugs Market Value (US$ Mn), by Region, 2018
Source: Coherent Market Insights Analysis (2020)
The rising research and development activities is expected to boost growth of the colonoscopy bowel preparation drugs market
Colonoscopy bowel preparation drugs market is expected to witness significant growth, owing to rising research and development activities for the development of innovative bowel preparation drugs, in order to offer better products in the market. For instance, in December 2019, ColonaryConcepts LLC, a biotechnological company engaged in the development of colon preparation products, announced the Phase III clinical trial of its Edible Colonoscopy (EC) preparation used for bowel cleansing.
Colonoscopy bowel preparation drugs market is expected to witness significant growth, owing to increasing adoption of agreement and collaboration strategies by the market players. For instance, in January 2019, Norgine B.V. and KOREA PHARMA CO., LTD., a premier pharmaceutical manufacturer in Korea, entered into an exclusive license and distribution agreement in the Republic of Korea, by which Korea Pharma will commercialize and distribute Norgine’s product, PLENVU, in Korea.
The rising prevalence of colorectal cancer is further expected to bolster colonoscopy bowel preparation drugs market growth over the forecast period. For instance, according to the World Cancer Research Fund and American Institute of Cancer Research report 2018, Hungary accounts for the highest rate of colorectal cancer of 51.2 per 100,000 population in 2018.
Figure 2. Global Colonoscopy Bowel Preparation Drugs Market Share (%), by Product Type, 2019 and 2027
Source: Coherent Market Insights Analysis (2020)
Colonoscopy Bowel Preparation Drugs Market - Regional Analysis
North America held a dominant position in the global colonoscopy bowel preparation drugs market in 2018, owing to rising incidence of colorectal cancer in the region. For instance, according to the Global Cancer statistics (GLOBOCAN) published in January 2020, in the U.S., around 147,950 new cases of large bowel cancer are diagnosed annually, of which around 104,610 cases are of colon cancer and the remaining are colorectal cancer. According to the same source, around 53,200 Americans die every year due to colorectal cancer, which accounts for around 8% of all cancer deaths occurring, globally.
Moreover, Europe is expected to witness significant growth in the colonoscopy bowel preparation drugs market during the forecast period, owing to rising adoption of inorganic growth strategies such as collaborations and agreements by key players, in order to expand their geographical presence and product portfolio. For instance, in October 2017, Norgine B.V. received marketing authorization from the UK Medicines and Healthcare Regulatory Agency (MHRA) for PLENVU (NER1006) for bowel cleansing in adults prior to colonoscopy.
https://www.coherentmarketinsights.com/insight/request-sample/3641
https://www.coherentmarketinsights.com/insight/request-pdf/3641
Key Players
Major players operating in the global colonoscopy bowel preparation drugs market include Ferring B.V., Bayer AG, Braintree, Bausch Health Companies Inc., and Norgine B.V.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.
What we provide:
- Customized Market Research Services
- Industry Analysis Services
- Business Consulting Services
- Market Intelligence Services
- Long term Engagement Model
- Country Specific Analysis
Mr. Shah
Coherent Market Insights Pvt. Ltd.
Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.
Phone: +1-206-701-6702
Email: [email protected]